Ipilimumab Intravenous and Hepatitis
Result of checking the interaction of drug Ipilimumab Intravenous and disease Hepatitis for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Immune-mediated hepatitis, including fatal cases, has occurred with ipilimumab therapy. In patients with hepatotoxicity, rule out infectious or malignant causes and increase frequency of liver function test monitoring until resolution. Ipilimumab must be permanently discontinued in patients with Grade 3 to 4 hepatotoxicity and appropriate measures should be taken. Withhold ipilimumab in patients with Grade 2 hepatotoxicity.
Generic Name: ipilimumab
Brand Name: Yervoy
Synonyms: Ipilimumab